OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 154 citing articles:

T cells in health and disease
Lina Sun, Yanhong Su, Anjun Jiao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 340

Role of sleep deprivation in immune-related disease risk and outcomes
Sergio Garbarino, Paola Lanteri, Nicola Luigi Bragazzi, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 316

Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy
Amrita Basu, Ganesan Ramamoorthi, Gabriella Albert, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 213

Thioredoxin Reductase Inhibition for Cancer Therapy
Radosveta Gencheva, Elias S.J. Arnér
The Annual Review of Pharmacology and Toxicology (2021) Vol. 62, Iss. 1, pp. 177-196
Closed Access | Times Cited: 102

Polysaccharides regulate Th1/Th2 balance: A new strategy for tumor immunotherapy
Qihang Shang, Xiaoyun Yu, Qi Sun, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 115976-115976
Open Access | Times Cited: 42

Therapeutic targeting of DNA methylation alterations in cancer
Abigail V. Lee, Kevin Nestler, Katherine B. Chiappinelli
Pharmacology & Therapeutics (2024) Vol. 258, pp. 108640-108640
Closed Access | Times Cited: 17

Dietary factors and their influence on immunotherapy strategies in oncology: a comprehensive review
Aleksandra Golonko, Tomasz Pienkowski, Renata Świsłocka, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 16

T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
Justin F. Gainor, Manish R. Patel, Jeffrey S. Weber, et al.
Cancer Discovery (2024) Vol. 14, Iss. 11, pp. 2209-2223
Closed Access | Times Cited: 15

Oncolysis without viruses — inducing systemic anticancer immune responses with local therapies
Oliver Kepp, Aurélien Marabelle, Laurence Zitvogel, et al.
Nature Reviews Clinical Oncology (2019) Vol. 17, Iss. 1, pp. 49-64
Closed Access | Times Cited: 126

Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond
Yun Hua Lee, David Tai, Connie Yip, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 115

Abscopal effect in radioimmunotherapy
Milad Ashrafizadeh, Bagher Farhood, Ahmed Eleojo Musa, et al.
International Immunopharmacology (2020) Vol. 85, pp. 106663-106663
Closed Access | Times Cited: 108

Role of Inflammatory Mediators, Macrophages, and Neutrophils in Glioma Maintenance and Progression: Mechanistic Understanding and Potential Therapeutic Applications
Abdul Samad Basheer, Faridah Abas, Iekhsan Othman, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4226-4226
Open Access | Times Cited: 73

The Anticancer Potential of Psidium guajava (Guava) Extracts
Bronwyn Lok, Dinesh Babu, Yasser Tabana, et al.
Life (2023) Vol. 13, Iss. 2, pp. 346-346
Open Access | Times Cited: 26

CAF-induced physical constraints controlling T cell state and localization in solid tumours
Ludovica Arpinati, Giulia Carradori, Ruth Scherz‐Shouval
Nature reviews. Cancer (2024) Vol. 24, Iss. 10, pp. 676-693
Closed Access | Times Cited: 11

Molecular mechanisms of TACE refractoriness: Directions for improvement of the TACE procedure
Jiahao Li, Yingnan Liu, Ruipeng Zheng, et al.
Life Sciences (2024) Vol. 342, pp. 122540-122540
Open Access | Times Cited: 9

Immunophenotypic Profiles in Polycystic Ovary Syndrome
聡 三戸, Bo Pang, Zhanchuan Ma, et al.
Mediators of Inflammation (2020) Vol. 2020, pp. 1-10
Open Access | Times Cited: 60

Diagnostic accuracy of quantitative dual-energy CT-based volumetric bone mineral density assessment for the prediction of osteoporosis-associated fractures
Leon D. Gruenewald, Vitali Koch, Simon S. Martin, et al.
European Radiology (2021) Vol. 32, Iss. 5, pp. 3076-3084
Open Access | Times Cited: 52

T lymphocytes in hepatocellular carcinoma immune microenvironment: insights into human immunology and immunotherapy.
Jin‐Song Bian, Jianzhen Lin, Junyu Long, et al.
American Journal of Cancer Research (2020) Vol. 10, Iss. 12, pp. 4585-4606
Closed Access | Times Cited: 51

Targeting of the tumor microenvironment by curcumin
Xiao Fu, Yingni He, Mu Li, et al.
BioFactors (2021) Vol. 47, Iss. 6, pp. 914-932
Closed Access | Times Cited: 50

An immunogenomic signature for molecular classification in hepatocellular carcinoma
Weiwei Zhuang, Hongwei Sun, Shanshan Zhang, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 25, pp. 105-115
Open Access | Times Cited: 49

DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma
Allison A. Fitzgerald, Shangzi Wang, Veena R. Agarwal, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 11, pp. e002837-e002837
Open Access | Times Cited: 48

Immunotherapy in triple-negative breast cancer: Insights into tumor immune landscape and therapeutic opportunities
Rita Ribeiro, Maria João Carvalho, João Gonçalves, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 34

Recent progress in the immunotherapy of hepatocellular carcinoma: Non-coding RNA-based immunotherapy may improve the outcome
Fatemeh Afra, Amir Ali Mahboobipour, Amir Salehi Farid, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115104-115104
Open Access | Times Cited: 18

The Synergistic Effect of Interventional Locoregional Treatments and Immunotherapy for the Treatment of Hepatocellular Carcinoma
Nicolò Brandi, Matteo Renzulli
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8598-8598
Open Access | Times Cited: 17

Page 1 - Next Page

Scroll to top